LIFEVANTAGE CORP Production Related Impairments or Charges
LIFEVANTAGE CORP (LFVN) reported Production Related Impairments or Charges of $0 for the 9-month period ending 2014-03-31, per its 10-Q filed 2014-05-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProductionRelatedImpairmentsOrCharges · last filed 2014-05-06
- LIFEVANTAGE CORP production related impairments or charges for the quarter ending 2014-03-31 was $0.00.
- LIFEVANTAGE CORP production related impairments or charges for the quarter ending 2013-03-31 was -$21.00K.
| Period end | Production Related Impairments or Charges 3 month | Production Related Impairments or Charges 6 month | Production Related Impairments or Charges 9 month |
|---|---|---|---|
| 2014-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-06 | $0.00 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $0.00 10-Q · filed 2014-02-06 | ||
| 2013-03-31 | -$21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-06 | $4.16M 10-Q · filed 2014-05-06 | |
| 2012-12-31 | $4.18M 10-Q · filed 2014-02-06 | ||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |